🎓 Markets 101June 11, 2026
China’s Looming Generic Wave Tests Novo Nordisk’s Ozempic Empire in the World’s Fastest-Growing GLP-1 Market
The GLP-1 receptor agonist class has delivered one of the most dramatic value creations in modern pharma history. Semaglutide (Ozempic for type 2 diabetes, Wegovy for chronic weight management) and tirzepatide (Mounjaro/Zepbound) have driven tens of billions in sales while addressing the global obesity and diabetes epidemics.
Nakitte Featured8 min